About Company
AVITA Medical is a leading regenerative medicine company focused on developing innovative solutions for wound care management and skin restoration. The company specializes in advanced medical devices that harness the regenerative properties of a patient’s own skin.
AVITA Medical is renowned for its flagship product, the RECELL® System, which is designed for the treatment of thermal burn wounds and full-thickness skin defects. This innovative device allows healthcare providers to create a regenerative epidermal suspension from a small sample of the patient's skin, enabling the application of "spray-on skin" cells directly to the wound site. This technology not only improves healing times but also enhances aesthetic outcomes for patients.The company also markets additional products like ReNovaCell for aesthetic applications and ReGenerCell for chronic wound treatment.
AVITA Medical has established a robust presence in various international markets, including Europe, the Middle East, Africa (EMEA), and Australia.AVITA Medical is publicly traded on both the NASDAQ under the ticker symbol RCEL and on the Australian Stock Exchange (ASX) as AVH. The company has received multiple FDA approvals and continues to expand its product offerings and clinical applications.